These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22693244)

  • 41. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
    Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of prognostic signature and nomogram for patients with breast cancer.
    Su J; Miao LF; Ye XH; Cui MS; He XF
    Medicine (Baltimore); 2019 Mar; 98(11):e14617. PubMed ID: 30882627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
    Griguolo G; Dieci MV; Giarratano T; Giorgi CA; Orvieto E; Ghiotto C; Berti F; Della Puppa A; Falci C; Mioranza E; Tasca G; Milite N; Miglietta F; Scienza R; Conte P; Guarneri V
    J Neurooncol; 2017 Jan; 131(2):369-376. PubMed ID: 27853958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.
    Le Scodan R; Massard C; Jouanneau L; Coussy F; Gutierrez M; Kirova Y; Lerebours F; Labib A; Mouret-Fourme E
    J Neurooncol; 2012 Jan; 106(1):169-76. PubMed ID: 21735114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.
    Chen K; Deng X; Yang Z; Yu D; Zhang X; Zhang J; Xie D; He Z; Cheng D
    Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):757-764. PubMed ID: 32552040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
    Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
    Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Factors and Prediction of Survival for Patients with Brain Metastases of Lung Adenocarcinoma.
    Zheng R; Guo D; Dong Y; Wang M; Hu M; Ren Y
    J Nippon Med Sch; 2021 Sep; 88(4):319-325. PubMed ID: 33455976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
    Li Y; Ma L
    BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
    Cheng S; Yang L; Dai X; Wang J; Han X
    BMC Cancer; 2021 Sep; 21(1):1057. PubMed ID: 34563149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation and comparison of CS-IHC4 scores with a nomogram to predict recurrence in hormone receptor-positive breast cancers.
    Park YH; Im SA; Cho EY; Ahn JH; Woo SY; Kim S; Keam B; Lee JE; Han W; Nam SJ; Park IA; Noh DY; Yang JH; Ahn JS; Im YH
    Oncology; 2014; 86(5-6):279-88. PubMed ID: 24903080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effective prognostic evaluation of breast cancer: using a STAR nomogram model based on routine blood tests.
    Wei C; Liang Y; Mo D; Lin Q; Liu Z; Li M; Qin Y; Fang M
    Front Endocrinol (Lausanne); 2024; 15():1324617. PubMed ID: 38529388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast-GPA 0-2.0.
    Ou D; Cao L; Xu C; Kirova Y; Chen JY
    Breast J; 2019 Nov; 25(6):1134-1142. PubMed ID: 31286612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis.
    Liu H; Xu YB; Guo CC; Li MX; Ji JL; Dong RR; Zhang LL; He XX
    Cancer Med; 2019 Dec; 8(18):7577-7585. PubMed ID: 31657530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients.
    Ma JY; Liu Q; Liu G; Peng S; Wu G
    Aging (Albany NY); 2021 Jun; 13(12):16684-16695. PubMed ID: 34185683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer.
    Wen J; Ye F; He X; Li S; Huang X; Xiao X; Xie X
    Oncotarget; 2016 Apr; 7(15):21046-53. PubMed ID: 26992235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases.
    Bergen ES; Berghoff AS; Medjedovic M; Rudas M; Fitzal F; Bago-Horvath Z; Dieckmann K; Mader RM; Exner R; Gnant M; Zielinski CC; Steger GG; Preusser M; Bartsch R
    Clin Cancer Res; 2019 May; 25(9):2737-2744. PubMed ID: 30647078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
    BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast cancer brain metastases - A 12 year review of treatment outcomes.
    De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
    Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.